A cell-based model of hemostasis

Thrombosis and Haemostasis

Volumn 85, Issue 6, 2001, Pages 958-965

  Hoffman, M ^a   Monroe III, D M ^a  

^a DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Blood coagulation; Platelets; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 9; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; PHOSPHATIDYLSERINE; PROTEINASE ACTIVATED RECEPTOR 1; PROTHROMBIN; THROMBIN; THROMBOCYTE RECEPTOR; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

BIOLOGICAL MODEL; BLOOD CLOTTING AND BLOOD CLOTTING FACTORS; CELL ACTIVITY; CELL SURFACE; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; RECEPTOR BINDING; REVIEW; THROMBIN TIME; THROMBOCYTE ACTIVATION;

EID: 0034971291     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615947     Document Type: Review

References (61)

1. Waterfall sequence for intrinsic blood clotting
2. An enzyme cascade in the blood clotting mechanism, and its function as a biological amplifier
3. Membrane and lipid involvement in blood coagulation
4. New perspectives on the coagulation cascade
5. Cellular interactions in hemostasis
6. Newer concepts of blood coagulation
7. Why do hemophiliacs bleed?
8. Factor XI activation in a revised model of blood coagulation
9. Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation
10. Factor XI activation by thrombin and factor XIa
11. Thrombin activates factor XI on activated platelets in the absence of factor XII
12. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin
13. Tissue factor: Molecular recognition and cofactor function
14. The crystal structure of the complex of blood coagulation factor VIIa with human soluble tissue factor
15. Blood-borne tissue factor: Another view of thrombosis
16. Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells
17. Activation of human factor V by factor Xa and thrombin
18. Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface
19. Activation of coagulation factor V by calcium-dependent proteinase
20. Transmission of a procoagulant signal from tissue factor-bearing cells to platelets
21. Thrombin facilitates primary platelet adhesion onto vascular surfaces in the absence of plasma adhesive proteins: Studies under flow conditions
22. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation
23. Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin
24. Modulation of thrombin-mediated activation of factor VIII:C by calcium ions, phospholipid, and platelets
25. Structural requirements for Factor IXa binding to platelets
26. Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo
27. Binding of coagulation factor XI to washed human platelets
28. Tissue factor as a tumor procoagulant
29. Factor X-dependent, thrombin-generating activities on a neuroblastoma cell and their disappearance upon differentiation
30. Changes in membrane phospholipid distribution during platelet activation
31. Multicellular eicosanoid and other metabolic interactions of platelets and cells
32. Comparative interactions of factor IX and factor IXa with human platelets
33. Modulation of the affinity of integrin alpha IIb beta 3 (GPIIb-IIIa) by the cytoplasmic domain of alpha II
34. Recombinant fragment of von willebrand factor AR545C inhibits platelet binding to thrombin and platelet adhesion to thrombin-treated endothelial cells
35. Platelet signal transduction pathways: Could we organize them into a 'hierarchy'?
36. Thrombin interaction with platelet membrane glycoprotein Ib
37. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity
38. The platelet high affinity binding site for thrombin mimics hirudin, modulates thrombin-induced platelet activation, and is distinct from the glycoprotein Ib-IX-V complex
39. Role of glycoprotein V in the formation of the platelet high-affinity thrombin-binding site
40. Defective thrombin-induced calcium changes and aggregation of Bernard- Soulier platelets are not associated with deficient moderate-affinity receptors
41. On the existence of platelet receptors for factor V(a) and factor VIII(a)
42. Platelet receptor-mediated factor X activation by factor IX. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome
43. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: A flow cytometric study
44. Structural and functional characterization of platelet receptor- mediated factor VIII binding
45. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin
46. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation
47. Xa receptor EPR-1
48. Factor XI binding to activated platelets is mediated by residues R(250), K(255), F(260), and Q(263) within the apple 3 domain
49. Activated factor VII activates factors IX and X on the surface of activated platelets: Thoughts on the mechanism of action of high-dose activated factor VII
50. Platelet activity of high dose factor VIIa is independent of tissue factor
51. Tumor necrosis factor-alpha modulation of glycoprotein Ib alpha expression in human endothelial and erythroleukemia cells
52. Interleukin-1 inhibits the synthesis of von Willebrand factor in endothelial cells, which results in a decreased reactivity of their matrix toward platelets
53. von Willebrand factor release and P-selectin expression is stimulated by thrombin and trypsin but not IL-1 in cultured human endothelial cells
54. The thrombomodulin/protein C/protein S anticoagulant pathway modulates the thrombogenic properties of the normal resting and stimulated endothelium
55. The active site of thrombin is altered upon binding to thrombomodulin
56. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex
57. Role of heparan sulfate proteoglycans in the uptake and degradation of tissue factor pathway inhibitor-coagulation factor Xa complexes
58. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39
59. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro
60. A possible mechanism of action of activated factor VII independent of tissue factor
61. Inhibition of thrombin generation by the zymogen factor VII: Implications for the treatment of hemophilia A by factor VIIa